News

Biotech Has Been Stalling. 3 Stocks That Could See Healthy Gains.
Insmed, a biopharmaceutical specialist in rare diseases, is stealing the spotlight in 2025 with a stunning 62% gain, ...
These two strategists believe a melt-up in stocks — even from here — is a growing probability
Two market commentators believe investors are underestimating the potential for stocks to respond positively to fiscal and ...
Global stocks steady as investors brace for Fed meeting, tariff deadline
Equities were modestly higher on Wednesday while the U.S. dollar advanced as investors digested the latest economic data and ...
The Economy Is Slowing. Why That Won’t Spook the Fed—But Will Support Stocks.
The Bureau of Labor Statistics said the world’s biggest economy grew at an annualized rate of 3% over the three months ending ...
Wall Street is bullish on Meta's Q2 performance ahead of its earnings report: 'One of the best AI opportunity stocks'
Wall Street expects a strong Q2 earnings report from Meta. Analysts are watching for AI updates. Concerns include rising ...
COLO: Colombian Stocks Are Worth More Than The Market Thinks
International investors may have had their attention drawn to the Colombian market recently as a result of its rather ...
London stocks flat as investors assess mixed corporate earnings
British stocks held steady on Wednesday as investors assessed a mixed bag of corporate earnings while waiting for potential ...
M&A Is Back. These Stocks Could Be Targets.
M&A is back is in style again under President Donald Trump. That’s good news for investors in stocks such as C3.ai, Viking ...
US stocks close mostly higher after EU trade deal: Busy earnings week and Fed meet ahead
US stocks close mostly higher on an EU trade deal. S&P 500 and Nasdaq hit records, but Mag Seven earnings and the Fed meeting ...
US stocks dip and break Wall Street’s record-breaking, weeklong run
Wall Street’s weeklong, record-breaking run ran out of momentum. The S&P 500 slipped 0.3% Tuesday for its first drop after ...
Cautious insiders, euphoric investors and seasonal weakness — what could go possibly go wrong for stocks?
Leuthold Group’s Doug Ramsey pointed out that cyclical stocks are trading at a record premium versus defensives, suggesting ...